rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-4-18
|
pubmed:abstractText |
In vivo thymocyte maturation models were used to investigate the differentiation role of Bcl-2. In alpha/beta T cell receptor (TCR) class II-restricted transgenic mice, Bcl-2 was upregulated at the CD4+ CD8+ stage during positive selection. The lckpr-bcl2 transgene was bred onto MHC classes I-I- and II-I-, MHC-I-, and alpha/beta TCR backgrounds to determine whether Bcl-2 promoted thymocyte maturation in the absence of coreceptor-MHC interaction. Bcl-2 rescued CD8+ thymocytes in class I-I- and alpha/beta TCR in mice; however, they were not exported to the periphery. Bcl-2 had no effect on CD4 lineage maturation in class II-I- mice. No single-positive thymocytes accumulate in MHC-I- mice despite overexpressed Bcl-2. Thus, Bcl-2 enables selection of certain TCRs on class II molecules and their differentiation along the CD8 pathway; however, Bcl-2 did not substitute for positive selection. In RAG-1-I- mice, Bcl-2 promoted differentiation to the CD4+ CD8+ stage. Bcl-2 can promote thymocyte maturation at several control points.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/Homeodomain Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/RAG-1 protein,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1074-7613
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:geneSymbol |
lck<up>pr</up>
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
197-205
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7889408-Animals,
pubmed-meshheading:7889408-Antigens, CD4,
pubmed-meshheading:7889408-Antigens, CD8,
pubmed-meshheading:7889408-Cell Differentiation,
pubmed-meshheading:7889408-Histocompatibility Antigens Class I,
pubmed-meshheading:7889408-Histocompatibility Antigens Class II,
pubmed-meshheading:7889408-Homeodomain Proteins,
pubmed-meshheading:7889408-Mice,
pubmed-meshheading:7889408-Mice, Inbred C3H,
pubmed-meshheading:7889408-Mice, Inbred C57BL,
pubmed-meshheading:7889408-Mice, Transgenic,
pubmed-meshheading:7889408-Models, Biological,
pubmed-meshheading:7889408-Proteins,
pubmed-meshheading:7889408-Proto-Oncogene Proteins,
pubmed-meshheading:7889408-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:7889408-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:7889408-T-Lymphocytes,
pubmed-meshheading:7889408-Up-Regulation
|
pubmed:year |
1994
|
pubmed:articleTitle |
Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points.
|
pubmed:affiliation |
Howard Hughes Medical Institute, Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|